StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca global rebates, chargebacks & returns reserve balance ($M) ($M)

Form 20-F Note 2 & Note 19 — Rebates, Chargebacks & Returns

Latest, FY2025
9,681
Period ended Dec 31, 2025
Change on a year earlier
+24.0%
7,805 in FY2024
History
7 years
Since FY2019
Sources
4
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGlobal rebates, chargebacks & returns reserve balance ($M) ($M)Year on yearSource
FY2025Dec 31, 20259,681+24.0%Form 20-F FY2025 Annual Report ↗
FY2024Dec 31, 20247,805-0.2%Form 20-F FY2025 Annual Report ↗
FY2023Dec 31, 20237,817+28.6%Form 20-F FY2024 Annual Report ↗
FY2022Dec 31, 20226,078+14.7%Form 20-F FY2024 Annual Report ↗
FY2021Dec 31, 20215,298+11.0%Form 20-F FY2023 Annual Report ↗
FY2020Dec 31, 20204,772+8.2%Form 20-F FY2023 Annual Report ↗
FY2019Dec 31, 20194,410–Form 20-F FY2022 Annual Report ↗

Breakdown

What makes up global rebates, chargebacks & returns reserve balance ($m)

Cite this data

StockData. (2026). AstraZeneca Global rebates, chargebacks & returns reserve balance ($M) ($M), annual FY2019–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/gtn_accrual_global

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.